Trimetazidine (review of the latest foreign publications)
- Authors: Akatova E.V1
-
Affiliations:
- A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation
- Issue: Vol 20, No 10 (2018)
- Pages: 53-58
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/95084
- ID: 95084
Cite item
Full Text
Abstract
Review of the latest data of randomized studies, meta-analyses and experimental studies proving the effectiveness of trimetazidine in cardiovascular diseases and comorbid pathology.
Full Text
##article.viewOnOriginalSite##About the authors
E. V Akatova
A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation
Email: akev@list.ru
д-р мед. наук, проф. каф. госпитальной терапии №1 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1
References
- Tritto I, Wang Pe, Kuppusamy P. The Anti-Anginal Drug Trimetazidine Reduces Neutrophil-Mediated Cardiac Reperfusion Injury. Cardiovasc Pharmacol 2015; 46 (1): 89-98.
- Jeong Su Kim, Chang Hoon Kim, Kook Jin Chun. Effects of trimetazidine in patients with acute myocardial infarction: data from the Korean Acute Myocardial Infarction Registry. Clin Res Cardiol. doi: 10.1007/s00392-013-0611-0
- Szwed H, Sadowski Z, Elikowski W. Combination treatment in stable effort angina using trimetazidine and metoprolol Results of a randomized, double-blind, multicentre study (TRIMPOL II). Eur Heart J 2011; 22: 2267-74.
- Song Peng, Min Zhao, Jing Wan. The efficacy of trimetazidine on stable angina pectoris: A meta-analysis of randomized clinical trials. Int J Cardiol 2014; 177: 780-5.
- Kyoung-Ha Park, Woo Jung Park, Min-Kyu Kim. Effects of Trimetazidine on Endothelial Dysfunction After Sheath Injury of Radial Artery 2010 Elsevier Inc. Am J Cardiol 2010; 105: 1723-7.
- Jinsong Chen, Shanshan Zhou, Jing Jin. Chronic treatment with trimetazidine after discharge reduces the incidence of restenosis in patients who received coronary stent implantation: A 1-year prospective follow-up study. doi: 10.3892/mmr.2016.5773
- Glezer M.G, Vygodin V.A. Anti-Anginal Effectiveness and Tolerability of Trimetazidine Modified Release 80 Mg Once Daily in Stable Angina Patients in Real-World Practice. On behalf of ODA investigators. Adv Ther. https://doi.org/10.1007/s12325-018-0756-3//
- Dedkova E.N, Seidlmayer L.K, Blatter L.A. Mitochondria-mediated cardioprotection by trimetazidine in rabbit heart failure. J Mol Cell Cardiol 2013. pii: S0022-2828(13)00054-0. doi: 10.1016/j.yjmcc.2013.01.016
- Belardinelli R, Solenghi M, Volpe L. Trimetazidine improves endothelial dysfunction in chronic heart failure: an antioxidant effect. Online publish-ahead-of-print 24 April 2007.
- Fragasso G, Rosano G, Baek S.H. Effect of partial fatty acid oxidation inhibition with trimetazidine on mortality and morbidity in heart failure: Results from an international multicentre retrospective cohort study. Int J Cardiol 2012. http://dx.doi.org/10.1016/j.ijcard.2012.09.123
- Dengfeng Gao, Ning Ning, Xiaolin Niu. Trimetazidine: a meta-analysis of randomised controlled trials in heart failure. Heart 2011; 97: 278-86.
- Lei Zhang, Yizhou Lu, Hong Jiang. Additional Use of Trimetazidine in Patients With Chronic Heart Failure A Meta-Analysis. J Am Col Cardiol 2012; 59 (10).
- Xiaohan Xu, Weijun Zhang, Yujie Zhou. Effect of Trimetazidine on Recurrent Angina Pectoris and Left Ventricular Structure in Elderly Multivessel Coronary Heart Disease Patients with Diabetes Mellitus After Drug-Eluting Stent Implantation: A Single-Centre, Prospective, Randomized, Double-Blind Study at 2-Year Follow-Up. Springer International Publishing Switzerland 2014. Clin Drug Invest. doi: 10.1007/s40261-014-0170-9
